System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Huyen Tran is an expert in Hematology at The Alfred Hospital (Australia). As of September 2026, ScienceLeadR ranks Huyen Tran in the top 1% of experts worldwide for Cytopenia, Blood Platelet Disorders and Embolism and Thrombosis. Huyen Tran has authored 233 publications, the most recent in 2026, and is an investigator in 15 clinical trials, 3 of them ongoing. SLR score: 928 (community average: 125). How the SLR is computed.

LeadR Profile

Huyen Tran The Alfred Hospital Australia
928 ScienceLeadR Reputation 928

Unlock

Register Login
Network Map

Hematology

Subspecialties: Pharmacy - Public Health - Genetics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2004 - 2026
Source: PubMed

Monash University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 233

Citations

Citations: 5 211 1st author: 42 Last author: 50 Unique author: 1

Main journals

Blood 24
Haemophilia 13
Intern Med J 9
Med J Aust 9
Res Pract Thromb Haemost 9

Best Journals

N Engl J Med 6
JAMA 2
Circulation 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Current Status of National Haemophilia Registries in the Asia-Pacific Region: An AHAD-AP Registry Committee Survey.
PMID 42670767 — registries, hemophilia a		Haemophilia20260
Prothrombotic genetic variants and cancer-associated venous thromboembolism: defining thrombotic risk across tumor types.
PMID 42095241 — thromboembolism, hematology, neoplasms, alleles, venous thromboembolism		Haematologica20260
Emerging haemostatic sprays: From material design to clinical translation.
PMID 41806614 — hemorrhage, biocompatible materials, wounds and injuries		Biomater Adv20260
Clinical, psychological and quality of life outcomes up to 12-months following thrombosis with thrombocytopenia syndrome after ChAdOx1-S (AZD1222) vaccination in Australia.
PMID 41875690 — quality of life, vaccines, covid-19 vaccines, stress, physiological, vaccination, signs and symptoms, drug-related side effects and adverse reactions, psychological distress, thrombosis, thrombocytopenia		Vaccine20260
Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism.
PMID 41812192 — thromboembolism, embolism, hemorrhage, rivaroxaban, venous thromboembolism, thrombosis, apixaban		N Engl J Med Top journal20263

Clinical Studies 15

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3 Study Chair: 1

By phase:

Phase 3 11
N/A 2
Phase 4 2

By status:

Completed 5
Active not recruiting 4
Recruiting 3
Unknown 2
Terminated 1

By type:

Interventional 13
Observational 2

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 1
multicentric5to9 1
multicentricup10 13

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Follow up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
NCT06948318 — injections, skin, blood platelet disorders, safety, hemorrhage, blood, follow-up studies, skin manifestations, hemorrhagic disorders, immune system diseases, immune system, autoimmune diseases, blood platelets, purpura, thrombocytopenic, injections, subcutaneous, purpura, hematologic diseases, thrombocytopenia, purpura, thrombocytopenic, idiopathic, cytopenia		Phase 3Recruiting2025
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
NCT06722235 — injections, skin, blood platelet disorders, safety, hemorrhage, blood, skin manifestations, hemorrhagic disorders, immune system diseases, immune system, autoimmune diseases, blood platelets, purpura, thrombocytopenic, injections, subcutaneous, purpura, hematologic diseases, thrombocytopenia, purpura, thrombocytopenic, idiopathic, cytopenia		Phase 3Recruiting2025
The Long term Safety and Efficacy of SerpinPC in Subjects with Hemophilia Who Completed a Sponsored SerpinPC Clinical Trial
NCT06568302 — injections, hemophilia b, safety, hemophilia a, genes, apc, protein c		Phase 3Recruiting2024

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS